Advertisement

US Aims to Help More Cancer Patients Try Experimental Drugs

MARILYNN MARCHIONE, AP Chief Medical Writer
Created: June 03, 2019 06:02 PM

CHICAGO (AP) - U.S. drug regulators are launching a project aimed at giving more cancer patients a chance to try treatments that are not yet on the market but that have shown some promise in early testing.

Advertisement – Content Continues Below

Currently, when patients want what's called "compassionate use" access to an experimental drug, doctors must first plead their case to the drug company and then to the Food and Drug Administration if the company agrees.

Under the new plan, the FDA becomes the first stop and will assign someone to do the paperwork, so that when a drug company gets the request it knows the FDA already deemed it appropriate.

FDA officials say they can't force companies to provide access but hope that more will. The plan was announced Monday at a cancer conference in Chicago.

Credits

MARILYNN MARCHIONE, AP Chief Medical Writer

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement

Duluth Police Investigating Shots Fired Incident

Duluth to Request Proposals for Golf Course Land Development

Family Reunited with WWI Dog Tag After More than 80 Years

Benefit to be Held for Grand Lake Firefighter Battling Cancer

Interim Fire Chief Shawn Krizaj Recommended for Permanent Job

Tree Dedicated in Friendship Garden With Japanese Delegation

Advertisement